236 related articles for article (PubMed ID: 28306367)
1. The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma.
Chen Y; Zheng X; Chen B; Yang X; Zheng J; Zheng Z; Yang T; Liu T; Hu J
Leuk Lymphoma; 2017 Oct; 58(10):2349-2355. PubMed ID: 28306367
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas.
Chen YP; Jones D; Chen TY; Chang KC
Leuk Lymphoma; 2014 Sep; 55(9):2038-47. PubMed ID: 24180328
[TBL] [Abstract][Full Text] [Related]
4. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
6. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type.
Suzuki R; Yamaguchi M; Izutsu K; Yamamoto G; Takada K; Harabuchi Y; Isobe Y; Gomyo H; Koike T; Okamoto M; Hyo R; Suzumiya J; Nakamura S; Kawa K; Oshimi K;
Blood; 2011 Dec; 118(23):6018-22. PubMed ID: 21984805
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic significance of plasma Epstein-Barr virus DNA in patients with diffuse large B cell lymphoma].
An N; Xie YP; Xu Y; Shi PF; Qian SX
Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):839-841. PubMed ID: 29136714
[TBL] [Abstract][Full Text] [Related]
9. An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified.
Hoffmann JC; Chisholm KM; Cherry A; Chen J; Arber DA; Natkunam Y; Warnke RA; Ohgami RS
Hum Pathol; 2016 Feb; 48():9-17. PubMed ID: 26772393
[TBL] [Abstract][Full Text] [Related]
10. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
11. Estimating the global burden of Epstein-Barr virus-related cancers.
Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
[TBL] [Abstract][Full Text] [Related]
12. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.
Hayashino K; Yoshida C; Ayata Y; Yukawa R; Komura A; Nakamura M; Meguri Y; Yamamoto K; Oda W; Imajo K
J Clin Exp Hematop; 2024; 64(1):52-58. PubMed ID: 38538319
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS;
Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].
Liang Q; Ye ZY; Su ZL; Lin HL; Shao CK; Lin SX; Rao HL; Mei KY; Zhao T; Liu YH; Luo DL; Zhu MG; Chen SH; Lin TY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):291-5. PubMed ID: 20654150
[TBL] [Abstract][Full Text] [Related]
15. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
18. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.
Nakhoul H; Lin Z; Wang X; Roberts C; Dong Y; Flemington E
mSphere; 2019 Jul; 4(4):. PubMed ID: 31292228
[TBL] [Abstract][Full Text] [Related]
19. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.
Cho J; Kim SJ; Park S; Yoo KH; Ki CS; Ko Y; Kim WS
Ann Hematol; 2018 Aug; 97(8):1427-1436. PubMed ID: 29627879
[TBL] [Abstract][Full Text] [Related]
20. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.
Kataoka K; Miyoshi H; Sakata S; Dobashi A; Couronné L; Kogure Y; Sato Y; Nishida K; Gion Y; Shiraishi Y; Tanaka H; Chiba K; Watatani Y; Kakiuchi N; Shiozawa Y; Yoshizato T; Yoshida K; Makishima H; Sanada M; Onozawa M; Teshima T; Yoshiki Y; Ishida T; Suzuki K; Shimada K; Tomita A; Kato M; Ota Y; Izutsu K; Demachi-Okamura A; Akatsuka Y; Miyano S; Yoshino T; Gaulard P; Hermine O; Takeuchi K; Ohshima K; Ogawa S
Leukemia; 2019 Jul; 33(7):1687-1699. PubMed ID: 30683910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
